The Chicken or the Egg? Genetic Testing Coverage

IE users – if you are experiencing issues trying to register for this webinar, please use Chrome, Safari or Firefox.

Thurs., Aug. 16, 2018
1:00-2:00 PM ET/10:00 AM PT

Click here to register for this live educational webinar where attendees will gain a greater understanding of the genetics testing market and the CMS NCD decision regarding next-generation sequencing, as well as frameworks for evaluating genetic tests.

 

Genomic medicine has the potential to revolutionize clinical practice. Genetic tests can assess disease risk, inform preventive measures, predict optimal therapeutic regimens, and more.

 

Early detection through genetic screening can reduce the financial impact on members and health systems by lowering downstream cost of care. In order for members to widely benefit from advances in genomics, genetic tests must be incorporated into medical health plan design.

 

In this webinar, attendees will gain a greater understanding of the genetics testing market and the CMS NCD decision regarding next-generation sequencing, as well as frameworks for evaluating genetic tests.

 

Presenters:

Yuri Fesko, MD

Medical Director of Oncology

Quest Diagnostics

 

Suzanne Belinson, PhD, MPH

Executive Director of Clinical Markets,

Blue Cross and Blue Shield Association

 

Patrick James, MD

Chief Clinical Officer

Health Plans and Policy

Quest Diagnostics